Septerna, Inc. (SEPN) stock
SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30176% above fair value
$41.67−0.93 (-2.18%)
Close on Nov 16, 2026Market cap $1.95BP/E –Yield –
Septerna cash
Cash and short-term investments held at the end of each period.
Septerna's cash was $478.60M at Sep 30, 2026. For fiscal 2025 it was $391.09M, up 11.4% from the year before.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $391.09M | +11.4% |
| FY2024 | Dec 31, 2024 | $350.92M | +296.6% |
| FY2023 | Dec 31, 2023 | $88.48M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $478.60M | +0.9% |
| Q2 FY2026 | Jun 30, 2026 | $372.32M | +14.0% |
| Q1 FY2026 | Mar 31, 2026 | $347.40M | +3.4% |
| Q4 FY2025 | Dec 31, 2025 | $391.09M | +11.4% |
| Q3 FY2025 | Sep 30, 2025 | $474.35M | +263.4% |
| Q2 FY2025 | Jun 30, 2025 | $326.56M | +149.0% |
| Q1 FY2025 | Mar 31, 2025 | $336.01M | +313.1% |
| Q4 FY2024 | Dec 31, 2024 | $350.92M | +296.6% |
| Q3 FY2024 | Sep 30, 2024 | $130.53M | +32.5% |
| Q2 FY2024 | Jun 30, 2024 | $131.17M | – |
| Q1 FY2024 | Mar 31, 2024 | $81.34M | – |
| Q4 FY2023 | Dec 31, 2023 | $88.48M | – |
| Q3 FY2023 | Sep 30, 2023 | $98.52M | – |
See a number that looks wrong?